Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Introduction Neutrophil accumulation in a tissue is characteristic of inflammation and is observed in a variety of pathological conditions as disparate as infection, trauma, ischemia, and cancer. The process of tissue infiltration is best understood in bacterial infection, where neutrophils are selectively attracted in large numbers to phagocytose and kill the invaders. In other conditions neutrophils are presumably recruited as scavengers of damaged tissue or unwanted extracellular deposits like immune complexes or fibrin. Phagocytosis is accompanied by the release of granule enzymes, superoxide, H202, and a variety of bioactive lipids. Several of these products are required for the killing and digestion of microorganisms. They also induce inflammation and tissue damage, however, which is normally observed after neutrophil accumulation. Several neutrophil chemoattractants have been characterized in recent years; the best known are the anaphylatoxin C5a (1), formylmethionyl peptides of bacterial origin (2), plateletactivating factor (PAF; 3),1 and leukotriene B4 (LTB4; 4). These stimuli have different origins and modes of formation, and their occurrence in disease must thus be expected to vary in accord with the underlying pathophysiological process. C5a is formed upon complement activation via the classical pathway after interaction of microorganisms with antibodies or the formation of immune complexes, or via the alternative pathway after the nonimmune recognition of foreign materials. In bacterial infections, on the other hand, formylmethionyl peptides (which are released by the microorganisms) are likely to be the major attractants. PAFand LTB4 are of special interest because they can be generated by the neutrophils themselves and may thus function as autoor paracrine amplifiers of the responses elicited by other stimuli (5). It has been shown that CSa, formylmethionyl peptides, PAF, and LTB4 act via unrelated receptors, suggesting that neutrophil recruitment can result from the concerted action of multiple stimuli.

[1]  B. Dewald,et al.  The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils , 1989, The Journal of experimental medicine.

[2]  J. Besemer,et al.  Specific binding, internalization, and degradation of human neutrophil activating factor by human polymorphonuclear leukocytes. , 1989, The Journal of biological chemistry.

[3]  B. Dewald,et al.  Histamine and sulfidoleukotriene release from human basophils: different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil-activating peptide NAF. , 1989, International archives of allergy and applied immunology.

[4]  R. Strieter,et al.  Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. , 1989, The Journal of biological chemistry.

[5]  J. Westwick,et al.  Novel neutrophil-stimulating peptides. , 1989, Immunology today.

[6]  B. Dewald,et al.  In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. , 1989, The American journal of pathology.

[7]  M. Baggiolini,et al.  A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils. , 1989, Biochemical and biophysical research communications.

[8]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[9]  R. Strieter,et al.  Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. , 1989, Science.

[10]  J. Shabanowitz,et al.  Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K. Matsushima,et al.  Brief Definitive Report Identification and Characterization of Specific Receptors for Monocyte-derived Neutrophil Chemotactic Factor (mdncf) on Human Neutrophils , 2022 .

[12]  M. Yamada,et al.  Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). , 1989, Biochemical and biophysical research communications.

[13]  T. Mosmann,et al.  A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. , 1989, Journal of immunology.

[14]  J. Schröder,et al.  Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. , 1989, Journal of immunology.

[15]  E. Appella,et al.  Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. , 1989, Molecular immunology.

[16]  A. Cerami,et al.  Identification and characterization of macrophage inflammatory protein 2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Dewald,et al.  Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Strieter,et al.  Monokine-induced gene expression of a human endothelial cell-derived neutrophil chemotactic factor. , 1988, Biochemical and biophysical research communications.

[19]  B. Dewald,et al.  Two transduction sequences are necessary for neutrophil activation by receptor agonists. , 1988, The Journal of biological chemistry.

[20]  J. Westwick,et al.  Elevation of PMN cytosolic free calcium and locomotion stimulated by novel peptides from IL-1-treated human synovial cell cultures. , 1988, Biochemical and biophysical research communications.

[21]  M. Baggiolini,et al.  Mechanism of neutrophil activation by NAF, a novel monocyte‐derived peptide agonist , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  R. Derynck,et al.  Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin. , 1988, The EMBO journal.

[23]  E. Appella,et al.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[24]  B. Dewald,et al.  A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.

[25]  T. Martin,et al.  A peptide from alveolar macrophages that releases neutrophil enzymes into the lungs in patients with the adult respiratory distress syndrome. , 1988, The American review of respiratory disease.

[26]  D. Remick,et al.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. , 1988, The Journal of biological chemistry.

[27]  J. van Beeumen,et al.  A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity , 1988, The Journal of experimental medicine.

[28]  J. Schröder,et al.  Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). , 1988, Biochemical and biophysical research communications.

[29]  L. Moldawer,et al.  Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties , 1988, The Journal of experimental medicine.

[30]  B. Dewald,et al.  Effects of PAF on neutrophils and mononuclear phagocytes. , 1988, Progress in biochemical pharmacology.

[31]  M. Baggiolini,et al.  Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. , 1987, Biochemical and biophysical research communications.

[32]  E. Appella,et al.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Schröder,et al.  Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. , 1987, Journal of immunology.

[34]  L. Bardwell,et al.  Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Matsushima,et al.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.

[36]  C. Weissmann,et al.  Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes. , 1987, Journal of immunology.

[37]  A. Tauber Protein kinase C and the activation of the human neutrophil NADPH-oxidase. , 1987, Blood.

[38]  J. Schröder,et al.  Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. , 1986, The Journal of investigative dermatology.

[39]  H. Ochs,et al.  An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. , 1986, Journal of immunology.

[40]  A. Henschen,et al.  Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin. , 1986, Biochemistry.

[41]  R. Snyderman,et al.  Receptor-coupled activation of phosphoinositide-specific phospholipase C by an N protein. , 1986, Science.

[42]  R. Colman,et al.  Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. , 1985, The American review of respiratory disease.

[43]  R. Cotran,et al.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.

[44]  P. Parsons,et al.  Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome. , 1985, The American review of respiratory disease.

[45]  Andrew D. Luster,et al.  γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.

[46]  T. Hugli,et al.  Structure and function of the anaphylatoxins , 1985 .

[47]  Michael J. Berridge,et al.  Inositol trisphosphate, a novel second messenger in cellular signal transduction , 1984, Nature.

[48]  T. Hugli Structure and function of the anaphylatoxins. , 1984, Springer seminars in immunopathology.

[49]  C B Wollheim,et al.  Is cytosolic ionized calcium regulating neutrophil activation? , 1983, Science.

[50]  M. Schork,et al.  Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.

[51]  J. W. Miller,et al.  Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Lefkowitz,et al.  The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states. , 1982, Biochemical and biophysical research communications.

[53]  R. Spragg,et al.  Studies on the pathogenesis of the adult respiratory distress syndrome. , 1982, The Journal of clinical investigation.

[54]  R. Crystal,et al.  Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. , 1981, The Journal of clinical investigation.

[55]  M. A. Bray,et al.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.

[56]  B. Dewald,et al.  Cellular mechanisms of proteinase release from inflammatory cells and the degradation of extracellular proteins. , 1979, Ciba Foundation symposium.

[57]  D. Pepper,et al.  Complete covalent structure of human beta-thromboglobulin. , 1978, Biochemistry.

[58]  P. Henson,et al.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. , 1978, Journal of immunology.

[59]  R. Heinrikson,et al.  Amino acid sequence of human platelet factor 4. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Lefkowitz,et al.  Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[61]  S. Wahl,et al.  N-formylmethionyl peptides as chemoattractants for leucocytes. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Cederberg,et al.  STUDIES ON THE ELIMINATION OF GRANULOCYTES IN THE INTESTINAL TRACT IN RAT. , 2009, Acta pathologica et microbiologica Scandinavica.